共 50 条
[18F]FDOPA uptake in the raphe nuclei complex reflects serotonin transporter availability. A combined [18F]FDOPA and [11C]DASB PET study in Parkinson's disease
被引:42
作者:
Pavese, N.
[1
]
Simpson, B. S.
[1
]
Metta, V.
[2
,3
,4
]
Ramlackhansingh, A.
[1
]
Chaudhuri, K. Ray
[2
,3
,4
]
Brooks, D. J.
[1
]
机构:
[1] Univ London Imperial Coll Sci Technol & Med, Dept Med, Ctr Neurosci, London, England
[2] Kings Coll London, Natl Parkinson Fdn, Ctr Excellence, London WC2R 2LS, England
[3] Lewisham Hosp NHS Trust, London, England
[4] Kings Coll London, Biomed Res Ctr, London WC2R 2LS, England
来源:
基金:
英国医学研究理事会;
关键词:
Positron emission tomography (PET);
F-18]FDOPA;
C-11]DASB serotonin Parkinson;
Monoamine;
Extrastriatal;
F-18-DOPA PET;
I-123-BETA-CIT SPECT;
CONTAINING NEURONS;
FLUORODOPA UPTAKE;
F-18;
FLUORODOPA;
MIDBRAIN;
DOPAMINE;
BINDING;
DORSAL;
BRAIN;
D O I:
10.1016/j.neuroimage.2011.09.034
中图分类号:
Q189 [神经科学];
学科分类号:
071006 ;
摘要:
Brain uptake of [F-18]FDOPA, measured with PET, reflects the activity of aromatic amino acid decarboxylase, an enzyme largely expressed in monoaminergic nerve terminals. This enzyme catalyzes a number of decarboxylation reactions including conversion of L-dopa into dopamine and 5-hydroxytryptophan into serotonin. For more than 20 years [F-18]FDOPA PET has been used to assess dopaminergic nigrostriatal dysfunction in patients with Parkinson's disease (PD). More recently, however, [F-18]FDOPA PET has also been employed as a marker of serotoninergic and noradrenergic function in PD patients. In this study, we provide further evidence in support of the view that [F-18]FDOPA PET can be used to evaluate the distribution and the function of serotoninergic systems in the brain. Eighteen patients with PD were investigated with both [F-18]FDOPA and [C-11]DASB PET, the latter being a marker of serotonin transport (SERT) availability. We then assessed the relationship between measurements of the two tracers within brain serotoninergic structures. [F-18]FDOPA uptake in the median raphe nuclei complex of PD patients was significantly correlated with SERT availability in the same structure. Trends towards significant correlations between [F-18]FDOPA Ki values and [C-11]DASB binding values were also observed in the hypothalamus and the anterior cingulate cortex, suggesting a serotoninergic contribution to [F-18]FDOPA uptake in these regions. Conversely, no correlations were found in brain structures with mixed dopaminergic, serotoninergic and noradrenergic innervations, or with predominant dopaminergic innervation. These findings provide evidence that [F-18]FDOPA PET represents a valid marker of raphe serotoninergic function in PD and supports previous studies where [F-18]FDOPA PET has been used to assess serotoninergic function in PD. (C) 2011 Elsevier Inc. All rights reserved.
引用
收藏
页码:1080 / 1084
页数:5
相关论文
共 50 条